Total Pharmacy Interviews

In part 2, Vanessa Slowey explains the pharmacy industry’s need for due diligence as technology reinforces patient convenience in the 21st century.

Vanessa Slowey lays the ground for where AI and automation are impacting pharmacy practice today and discusses what innovations are still expected.

Presenting what they believe are the problems and solutions, PCMA CEO David Marin and NCPA CEO Douglas Hoey, RPh, discuss the US drug pricing dilemma.

Scott Stoll and Kenzie Hohman, PharmD, discuss the importance of pharmacy advocacy, from localized efforts to federal movement across the profession.

In part 2, Scott Stoll and Kenzie Hohman, PharmD, explain their respective advocacy efforts, highlighting the sheer range of a profession fighting for change.

Kenzie Hohman, PharmD, and Scott Stoll believe pharmacy advocacy is inherent in its workforce, despite the constant and deterrent pressures it faces.

Through real-world strategies and examples, Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, assess the pharmacist’s growing prescribing capabilities.

Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, share real-world examples of how pharmacists’ medication expertise is transformative for patients.

Duane Jones, BS Pharm, and Jennifer Griffin, PharmD, provide their reasons behind the need for expanding pharmacists’ prescribing abilities.

Rick Couldry, MS/HSPA, discusses how cloud-native software resolves fragmented systems, improves tracking, and streamlines clinical workflows.

In part 2, Rick Couldry, MS/HSPA, provides necessary nuance to the value driving cloud-based medication management to the forefront of health care.

Rick Couldry, MS/HSPA, provides his expertise for why medication management requires modernization to further streamline patient outcomes.

Rae McMahan joins to provide key insights and updates on developing action between CVS Caremark, the FTC, and the rest of the pharmacy benefits industry.

In part 2, Blank argues that the language on a medication’s label deserves the same regulatory scrutiny given to the drugs themselves and how they affect patients.

Often operating in the shadows, LTC pharmacy is the backbone of medication management for aging and immunocompromised patients.

In part 2 of our interview series with Lisa Lavin, she explored the capabilities of her company’s Home Health Hub and how it’s transforming health care access for rural populations.

Lisa Lavin, founder, chairman, and CEO of Ōmcare, discusses the Rural Health Innovation Initiative and how collaboration is bringing pharmacy care to rural Minnesota and beyond.

In a shifting environment, pharmacy success is no longer just about scale but about earning patient trust through consistency and effectively managing affordability.

Pharmacy reimbursement stability is built on transparency, financial visibility, and an understanding of upcoming industry shifts.

As PBM-pharmacy relationships evolve in real time, staying proactive when a PBM audit comes through could be the difference between thriving and losing essential business.

In part 2, Harini Bupathi, Esq, dives deeper into PBMs’ goals behind pharmacy audits and how that could all change with recent reform measures.

Community pharmacies have become one of the most accessible points of care for patients, especially in rural and underserved communities.

As clinical roles expand, the need for robust pharmacy infrastructure to streamline workflows and ensure medication access has never been more critical.

With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.

From PBM reform and AI to burnout and closures, Tom DePietro, PharmD, addresses the current state of independent pharmacy.

In part 2, Tom DePietro, PharmD, explores emerging topics of interest within community pharmacy, including AI, PBMs, and the industry’s evolving nature.

From PBM reform designed to benefit pharmacies to closures impacting the greater public health sector, Tom DePietro, PharmD, discusses current developments in community pharmacy.

With value-based care initiatives on the rise in the US health care system, one partnership in Ohio is showing early signs of significant success.

In part 2, Kevin Day, PharmD, breaks down the Pharmacy Quality Rewards Program and its push toward value-based care in pharmacy practice.

In an evolving pharmacy landscape, accreditation can be difficult to manage, which is why experts like Mitch Lamb, PharmD, can steer businesses onto their desired paths.